BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34377104)

  • 21. Evaluation of image registration in subtracted 3D dynamic contrast-enhanced MRI of treated hepatocellular carcinoma.
    Sundarakumar DK; Wilson GJ; Osman SF; Zaidi SF; Maki JH
    AJR Am J Roentgenol; 2015 Feb; 204(2):287-96. PubMed ID: 25615750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging.
    Chou CT; Chen RC; Chen WT; Lii JM
    Clin Radiol; 2009 Jan; 64(1):22-9. PubMed ID: 19070694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging (MRI) in 100 cases of mass lesions in the liver.
    Meng T; Su XZ
    Chin Med J (Engl); 1990 Aug; 103(8):673-9. PubMed ID: 2173656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic T2-weighted MRI: a prospective comparison of sequences, including breath-hold, half-Fourier turbo spin echo (HASTE).
    Coates GG; Borrello JA; McFarland EG; Mirowitz SA; Brown JJ
    J Magn Reson Imaging; 1998; 8(3):642-9. PubMed ID: 9626880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study.
    An C; Lee CH; Byun JH; Lee MH; Jeong WK; Choi SH; Kim DY; Lim YS; Kim YS; Kim JH; Choi MS; Kim MJ
    Korean J Radiol; 2019 Dec; 20(12):1616-1626. PubMed ID: 31854149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
    Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
    Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Texture analysis of MR images to identify the differentiated degree in hepatocellular carcinoma: a retrospective study.
    Feng M; Zhang M; Liu Y; Jiang N; Meng Q; Wang J; Yao Z; Gan W; Dai H
    BMC Cancer; 2020 Jun; 20(1):611. PubMed ID: 32605628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small hepatocellular carcinoma versus small cavernous hemangioma: differentiation with MR imaging at 2.0 T.
    Choi BI; Han MC; Kim CW
    Radiology; 1990 Jul; 176(1):103-6. PubMed ID: 2162066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplant for mixed capillary-cavernous hemangioma masquerading as hepatocellular carcinoma in a patient with hepatocellular carcinoma.
    Unal E; Francis F; Aquino A; Xu R; Morgan G; Teperman L
    Exp Clin Transplant; 2011 Oct; 9(5):344-8. PubMed ID: 21967263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
    Helmberger TK; Laubenberger J; Rummeny E; Jung G; Sievers K; Döhring W; Meurer K; Reiser MF
    Eur Radiol; 2002 Jan; 12(1):62-70. PubMed ID: 11868075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of hepatic neoplasms.
    DiMarcangelo MT
    J Am Osteopath Assoc; 1992 Oct; 92(10):1261-6. PubMed ID: 1334061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
    Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.
    Chou CT; Chen RC; Chen WT; Lii JM
    Br J Radiol; 2010 Dec; 83(996):1023-8. PubMed ID: 20413445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
    Quillin SP; Atilla S; Brown JJ; Borrello JA; Yu CY; Pilgram TK
    Magn Reson Imaging; 1997; 15(3):275-85. PubMed ID: 9201674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.